UCB, Inc. et al v. Annora Pharma Private Limited
UCB, Inc. and UCB Biopharma SRL |
Annora Pharma Private Limited |
1:2023cv00243 |
March 6, 2023 |
US District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on April 4, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 SO ORDERED, re #9 Stipulation to Stay Proceedings, filed by UCB, Inc., UCB Biopharma SRL. Case stayed. Signed by Judge Colm F. Connolly on 4/4/2023. (kmd) |
Filing 9 STIPULATION and [Proposed] Order to Stay Proceedings by UCB Biopharma SRL, UCB, Inc.. (Dellinger, Megan) |
Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 7 SUMMONS Returned Executed by UCB, Inc., UCB Biopharma SRL.Annora Pharma Private Limited served on 3/6/2023, answer due 3/27/2023. (Dellinger, Megan) |
Filing 6 Summons Issued as to Annora Pharma Private Limited on 3/6/2023. (vfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB SA, Corporate Parent UCB, Inc., Corporate Parent UCB Pharma SA, Corporate Parent UCB Manufacturing, Inc. for UCB Biopharma SRL; Corporate Parent UCB SA, Corporate Parent UCB Holdings, Inc. for UCB, Inc. filed by UCB Biopharma SRL, UCB, Inc. (vfm) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,911,461 B2. (vfm) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/21/2023. Date of Expiration of Patent: 02/21/2026.Thirty Month Stay Deadline: 8/21/2025. (vfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Annora Pharma Private Limited (Filing fee $ 402, receipt number ADEDC-4082700.) - filed by UCB, Inc., UCB Biopharma SRL. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.